|
ニューズレター
|
 |
A major new business intelligence service for pharmaceutical executives
For the pharmaceutical industry, research interest has never been higher as the hunt for blockbuster products that offer truly improved economic outcomes and real patient benefits is contested by nearly every major research-based company.
Cardiovascular Drug News takes the hard work out of staying in touch with the companies, products, alliances and research that are shaping the global cardiovascular drug markets. Incorporating primary source material augmented with data from Espicom's unique intelligence database, Cardiovascular Drug News provides a compelling, easy-to-read route to complete market knowledge.
The following sections will appear in every issue:
- General Development News
- International Conference Listings
A selection of the following topics will appear each month, depending on news availability:
- Arrhythmias/Cardiac Failure
- Antihypertensives
- Circulatory Disorders
- Anticoagulants/Antithrombotics & Fibrinolytics
- Haemostatics
- Hypolipidaemic Agents
- Anaemia & Neutropenia
|
|
